Cardiovascular Systems Inc. | Balance Sheet

Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
126,592.00
85,718.00
61,322.00
108,616.00
116,804.00
Total Accounts Receivable
21,383.00
30,830.00
23,128.00
28,472.00
31,225.00
Inventories
12,890.00
13,966.00
17,440.00
16,897.00
16,605.00
Other Current Assets
1,846.00
3,380.00
2,992.00
5,074.00
2,977.00
Total Current Assets
162,711.00
133,894.00
104,882.00
159,059.00
167,611.00
Net Property, Plant & Equipment
15,297.00
32,883.00
32,471.00
29,696.00
27,744.00
Total Investments and Advances
-
-
-
-
2,538.00
Intangible Assets
3,823.00
4,511.00
5,013.00
5,056.00
5,231.00
Other Assets
70.00
40.00
40.00
129.00
228.00
Total Assets
181,901.00
171,328.00
142,406.00
193,940.00
203,352.00
ST Debt & Current Portion LT Debt
2,400.00
-
-
-
-
Accounts Payable
12,699.00
9,763.00
8,506.00
10,736.00
10,441.00
Income Tax Payable
-
-
3,372.00
3,497.00
3,522.00
Other Current Liabilities
14,630.00
20,125.00
23,621.00
26,739.00
23,497.00
Total Current Liabilities
29,729.00
29,888.00
35,499.00
40,972.00
37,460.00
Long-Term Debt
-
-
-
21,100.00
21,064.00
Other Liabilities
117.00
2,005.00
6,010.00
13,479.00
9,898.00
Total Liabilities
29,846.00
31,893.00
41,509.00
75,551.00
68,422.00
Common Equity (Total)
152,055.00
139,435.00
100,897.00
118,389.00
134,470.00
Total Shareholders' Equity
152,055.00
139,435.00
100,897.00
118,389.00
134,470.00
Total Equity
152,055.00
139,435.00
100,897.00
118,389.00
134,470.00
Liabilities & Shareholders' Equity
181,901.00
171,328.00
142,406.00
193,940.00
203,352.00
Non-Equity Reserves
-
-
-
-
460.00

About Cardiovascular Systems

View Profile
Address
1225 Old Highway 8 Northwest
St. Paul Minnesota 55112
United States
Employees -
Website http://www.csi360.com
Updated 07/08/2019
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. Its products are primarily catheter-based platforms capable of treating a range of vessel sizes and plaque types.